Re: [討論] 關於ligand targeted therapy

看板Biology (生物學)作者 (What's life?  N)時間18年前 (2008/04/29 14:35), 編輯推噓2(204)
留言6則, 2人參與, 最新討論串10/14 (看更多)
In a sense, I just see an NTU college student, also a political maniac, show off his limited biological scope to an NTU master who merely pursues the answer to the availability of ligand-conjugated liposomes for cancer treatments. The original question is whether such ligand-conjugated liposomes stand a chance to be approved by FDA or be on sale even if they are vulnerable to be expired or degraded in short time owing to the instability and storage difficulty of these ligand-conjugated liposomes. -- ※ 發信站: 批踢踢實業坊(ptt.cc) ◆ From: 140.109.49.211 ※ 編輯: tk 來自: 140.109.49.211 (04/29 14:45) ※ 編輯: tk 來自: 123.193.180.96 (04/29 23:10)

04/30 12:57, , 1F
your point? English practice?
04/30 12:57, 1F

04/30 12:58, , 2F
有沒有該領域的前輩可以發表一下高見的...
04/30 12:58, 2F

04/30 12:59, , 3F
因為這應該是許多對DDS有興趣的後輩(我在內)關切的話題吧
04/30 12:59, 3F

05/01 00:19, , 4F
看到這種討論方式結論是, 大家都很厲害可以自己看
05/01 00:19, 4F

05/01 00:20, , 5F
Nature Review Cancer, Drug Discovery, Immunology
05/01 00:20, 5F

05/01 00:22, , 6F
自己email詢問author, 不需要來這邊問問題
05/01 00:22, 6F
※ 編輯: tk 來自: 140.109.49.211 (05/01 17:56)
文章代碼(AID): #185i6LQz (Biology)
討論串 (同標題文章)
文章代碼(AID): #185i6LQz (Biology)